AstraZeneca nối lại thử nghiệm vắcxin ngừa COVID-19
Ngày 12/9, hãng dược phẩm liên doanh Anh-Thụy Điển AstraZeneca đã thông báo nối lại thử nghiệm lâm sàng theo cách thức ngẫu nghiên đối với vắcxin AZD1222 - một trong những loại vắcxin được đánh giá có tiềm năng nhất ngừa bệnh viêm đường hô hấp cấp COVID-19 hiện nay.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu